AstraZeneca nối lại thử nghiệm vắcxin ngừa COVID-19
Ngày 12/9, hãng dược phẩm liên doanh Anh-Thụy Điển AstraZeneca đã thông báo nối lại thử nghiệm lâm sàng theo cách thức ngẫu nghiên đối với vắcxin AZD1222 - một trong những loại vắcxin được đánh giá có tiềm năng nhất ngừa bệnh viêm đường hô hấp cấp COVID-19 hiện nay.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu